INTRODUCTION

Top Abstract Introduction Materials and Methods Results Discussion References

Hematopoietic stem cells are an attractive target for gene therapy, as they can both self-renew and differentiate into all blood lineages, thus supporting hematopoiesis throughout the lifetime. Gene transfer into hematopoietic stem cells can potentially provide a cure for many inherited and acquired diseases of the hematopoietic and immune systems (25). So far the success of gene therapy in the hematopoietic system has been limited by inefficient gene transfer. Due to the quiescent nature of human hematopoietic stem cells, they are fairly poor targets for conventional oncoretrovirus vectors, which require cell division for integration (22, 26). Lentivirus proteins have nuclear localization signals which facilitate entry of the preintegration complex into the nuclei of nondividing cells (4, 22, 42). This enables lentivirus vectors to transduce nondividing cells, and they therefore represent a promising tool for gene therapy of hematopoietic stem cells (27, 30, 31, 36, 38, 40). Lentivirus gene transfer vectors have been shown to transduce both dividing and nondividing cells from various species, including cell lines and primary cells such as neurons (2, 10, 12, 19, 44), myocytes (18), and hepatocytes (18, 34); retinal (28), corneal (41), cochlear (16), and, pancreatic islet (15) cells; and various populations of hematopoietic cells (1, 5, 11, 13, 30, 39, 40). Continuous vector development has focused on the generation of vectors that are both efficient and safe (32). The tropism of the vector is widened by pseudotyping the virus by vesicular stomatitis virus glycoprotein (VSV-G) envelope (23), which also provides high stability for the virus and facilitates concentration for high titers. For safety reasons the accessory genes vif, vpr, vpu, and nef, involved in the pathogenesis of wild-type human immunodeficiency virus (HIV), have been deleted. The probability of generation of replication-competent recombinants (RCRs) is minimized by segregating the cis- and trans-acting elements in three different plasmids, as well as developing self-inactivating lentiviruses with deletions in the U3 region of the 3' long terminal repeat (LTR) (29,45). Lentivirus vectors do not transduce any viral genes into the target cells, minimizing the likelihood of immune reactions. The ex vivo transduction used for hematopoietic cells omits the need to expose the patient to the virus systemically, reducing the risk of toxicity potentially associated with high quantities of the vector, as shown with in vivo transduction of murine hepatocytes (34).

Several studies have demonstrated the superiority of HIV type 1 (HIV-1)-based lentivirus vectors to oncoretrovirus vectors in transducing human hematopoietic progenitor cells and human candidate stem cells. This includes CD34⁺ cells from different sources including bone marrow, cord blood, and mobilized peripheral blood progenitor cells, as well as purified cells with the CD34⁺ CD38 immunophenotype (1, 5, 11, 13, 30, 39, 40) that are known to support long-term hematopoiesis. High transduction efficiency has been demonstrated in in vitro assays as well as in vivo in xenograft models, for example, in immunodeficient NOD/SCID mice which act as hosts for the transplantation of human hematopoietic cells (30). Although the NOD/SCID mouse assay is the most commonly used assay so far for the study of human candidate stem cells, it is limited by the short life span of the recipients as well as by the inability to support differentiation to all hematopoietic lineages.

The development of lentiviral gene therapy into clinical use will require preclinical trials in animal models. This will be invaluable for in vivo testing of new lentivirus vectors, e.g., to achieve optimal expression levels in differentiated progeny cells or to provide lineage-specific or regulatable expression of the transgene. The animal disease models are also crucial for testing the effects of lentivirus gene transfer in vivo, as well as assessing the safety of the vector system in immunocompetent hosts.

The aim of this work was to study the efficiency of lentivirus gene transfer into murine hematopoietic stem cells under quiescent and proliferating conditions. In this study we have demonstrated that purified Lin c-kit⁺ Sca1⁺ primitive murine hematopoietic progenitor cells can be transduced by lentivirus vectors under both quiescent as and cytokine-stimulated conditions and that high transgene expression levels can be achieved using the elongation factor 1 (EF-1) promoter. However, the transduction efficiency is consistently higher if the target cells are transduced with cytokine support. Furthermore, the final gene transfer efficiency in the daughter cells is compromised by a latency of lentivirus vector integration, and optimal gene transfer of primitive murine hematopoietic progenitor cells depends on adjustment of the cytokine stimulation and proliferation kinetics of the target cell during and after transduction.

	MATERIALS AND METHODS

Top Abstract Introduction Materials and Methods Results Discussion References

Lentivirus vector constructs. Lentivirus vectors were generated by transient transfection in 293T cells using the three-plasmid system as previously described (31). The packaging plasmid pCMV R8.91 provides the Gag, Pol, Tat, and Rev proteins to package the viral particle in 293T cells. The envelope coding plasmid pMD.G provides the vector with a VSV-G envelope, which broadens the host range and stabilizes the viral particle. The transfer vector plasmid, pHR'EF-1 GFP, contains the enhanced green fluorescent protein (GFP) marker gene (6, 7, 8, 35) driven by an internal promoter, EF-1 (a gift from Stuart Orkin, Children's Hospital, Boston, Mass.), as described earlier with other internal promoters (31). Additionally, three other internal promoters, PGK, CMV, or CAG (a hybrid promoter containing the chicken actin promoter and the CMV enhancer), were tested for expression in mouse hematopoietic cells. The promoters were also tested in self-inactivating (SIN) vectors where the U3 region of the 3' LTR is deleted to improve the safety of the vector system further (29, 45), as well as with the woodchuck hepatitis virus posttranscriptional regulatory element (WPRE) downstream from the transgene in an effort to provide high expression levels, as shown in Fig. 1 (46).

View larger version (15K): [in this window] [in a new window]   FIG. 1.   Lentivirus gene transfer vectors. The four internal promoters tested are shown. The WPRE element was added to the vectors containing the CAG, PGK, and EF-1 promoters and compared with those without WPRE. SIN vectors with PGK and CMV promoters were compared with the PGK and CMV vectors with normal LTRs.

Preparation of high-titer virus vectors. Lentivirus vectors were generated by transient transfection in 293T cells using the three-plasmid system as described earlier (31). Briefly, the transfection was performed by CaPO₄ precipitation in Dulbecco's modified Eagle medium (DMEM)-10% fetal bovine serum (Gibco BRL, Cleveland, Ohio)-100 IU of penicillin/ml-100 µg of streptomycin (Gibco BRL)/ml, followed by a medium change after 18 h. Viral supernatants were harvested 24 and 48 h later and concentrated by ultracentrifugation. The viral supernatants were titered on HeLa cells by serial dilutions and analyzed 96 h later by fluorescence-activated cell sorter (FACS) (FACS Calibur, Becton Dickinson Immunocytometry Systems, San Jose, Calif.) for the ratio of GFP⁺ cells. Lentivirus titers ranged from 5 × 10⁷ to 5 × 10⁸. For the oncoretrovirus control vector, the MGIN vector (containing the GFP gene followed by an internal ribosomal entry site [IRES] and the neomycin resistance gene driven by the vector LTR) (8) pseudotyped with the same envelope, VSV-G, was used. The MGIN vector plasmid (a gift from Robert Hawley, Holland Laboratory, American Red Cross, Rockville, Md.) was transfected into the GP+ env AM12 packaging cell line. The harvested supernatants were used to transduce the 293 GPG cell line (kindly provided by Richard Mulligan, Children's Hospital, Boston, Mass.) with tetracycline-controlled VSV-G expression (33) to obtain VSV-G-pseudotyped MGIN vector. For the oncoretrovirus transductions, both concentrated serum-free supernatants (titers, 2 × 10⁸ to 5 × 10⁸ transducing units [TU]/ml) and nonconcentrated serum-containing supernatants (titers, 1 × 10⁶ to 5 × 10⁷ TU/ml) were used.

Isolation of murine Lin c-kit⁺ Sca1⁺ hematopoietic progenitor cells. For isolation of murine hematopoietic progenitor and stem cells, bone marrow hematopoietic cells from femurs and tibias of 8- to 12-week-old C57/B6 donor mice were used. Lin⁺ cells were depleted by 2.8-µg/ml rat anti-mouse antibodies against Gr1, Mac1, B220, CD5, CD4, CD8, and Ter119 (PharMingen, San Diego, Calif.) and sheep anti-rat antibody-conjugated magnetic beads (M-450; Dynal, Oslo, Norway). The resulting Lin/Lin^low cells were stained with 20 µg of phycoerythrin (PE)-conjugated rat anti-mouse c-kit and fluorescein isothiocyanate (FITC)-conjugated rat anti-mouse Sca1 antibodies (PharMingen)/ml and sorted by FACS (FACS Vantage; Becton Dickinson Immunocytometry Systems). All isolation steps were performed on Iscove's modified Dulbecco's medium (IMDM; Gibco BRL) with 5% serum, 10⁴ M -mercaptoethanol (-ME), 100 IU of penicillin/ml, and 100 µg of streptomycin/ml.

Transduction of murine hematopoietic progenitor cells. Sorted cells were washed, and all lentivirus transductions and liquid cultures were performed in serum-free X-Vivo 15 medium (BioWhittaker, Walkersville, Md.) with 1% bovine serum albumin (Stem Cell Technologies, Vancouver, British Columbia, Canada), -ME, l-glutamine, and penicillin-streptomycin, with and without cytokine supplementation. The transductions were performed either in 96-well plates (non-tissue culture treated; Falcon; BD Biosciences, San Jose, Calif.) coated with fibronectin (Retronectin; Takara Shuzo, Otsu, Japan) or on terasaki plates (Falcon). In 96-well plates, 2,000 to 10,000 cells were transduced in each well in a volume of 100 µl, whereas in terasaki plates, 500 to 1,000 cells were transduced in each well in a volume of 20 µl. Viral supernatants were supplemented to result in a multiplicity of infection (MOI) of 100 HeLa TU/cell (final titers, 2 × 10⁶ to 5 × 10⁶). The transductions were performed for 20 h with 4 µg of protamine sulfate/ml either (i) without any cytokines, (ii) with 50 ng of rat stem cell factor (SCF)/ml, or (iii) with 50 ng of rat SCF/ml, 50 ng of human interleukin-6 (IL-6)/ml, and 10 ng of murine IL-3/ml. In an effort to aid reverse transcription of the viral genome, some transductions were supplemented with deoxynucleoside triphosphates (dNTPs). The dNTP solution (New England Biolabs, Beverly, Mass.) was diluted in water to make a stock solution and added to the culture medium at the same time as the viral supernatant. The final concentration of each dNTP was 50 µM. To improve transduction efficiency further, double transduction was performed by adding new viral supernatant at 20 h and incubating for an additional 20 h, resulting in a final transduction time of 40 h and a total MOI of 200 (Fig. 2).

View larger version (19K): [in this window] [in a new window]   FIG. 2.   Experimental design for studying lentivirus gene transfer and expression in murine hematopoietic stem cells

Methylcellulose colony assays. After the transduction, the cells were plated in methylcellulose containing SCF, IL-6, IL-3, and 20% fetal calf serum (FCS) in IMDM (Stem Cell Technologies). In selected experiments, the transduced cells were further cultured for an additional 24 to 72 h in SCF alone or SCF, IL-6, and IL-3 before plating into colony assays. The colonies were scored at days 6 to 7 for GFP expression by microscopy. Individual GFP⁺ colonies were also analyzed by FACS for GFP expression within each colony, or the cells from all colonies in the plate were pooled and analyzed by FACS for GFP expression in the progeny of all clonogenic progenitors. In selected experiments, primary GFP⁺ methylcellulose colonies were picked at day 6, after which each individual colony was split in two for FACS analysis and secondary plating in methylcellulose. The secondary colonies were cultured for 2 weeks, and each secondary colony was analyzed by microscopy, FACS, and PCR.

PCR from hematopoietic colonies. After scoring for GFP expression, individual methylcellulose colonies were picked for PCR analysis. The cells within each colony were lysed in a lysis buffer containing 105 mM KCl, 14 mM Tris HCl₂, 2.5 mM MgCl₂ (aqueous solution), 0.3 mg of gelatin/ml, 0.45% NP-40, 0.45% Tween 20, and 60 µg of proteinase K/ml and were incubated at 56°C for 1 h followed by 96°C for 15 min. The PCR to detect the presence of the vector gene was performed by primers within the GFP gene (GFP56F; 5' GAG CTG GAC GGC GAC GTA AAC G, and GFP629R, 5' CGC TTC TCG TTG GGG TCT TTG CT). Amplification was performed in 1.5 mM MgCl₂ with 30 cycles of 95, 60, and 72°C, and the PCR products were analyzed on ethidium bromide-agarose gels. The integrity of DNA samples was controlled by PCR for mouse actin.

	RESULTS

Top Abstract Introduction Materials and Methods Results Discussion References

Optimal lentivirus vector design for expression in murine hematopoietic cells. To select an optimal expression cassette for high expression of lentivirus-vectors in murine hematopoietic cells, 10 different expression vectors were tested in murine hematopoietic cells (Fig. 1). The vectors EF-1, EF-1-WPRE, PGK, PGK-SIN, PGK-WPRE-SIN, CMV, CMV-WPRE, CMV-SIN, CAG, and CAG-WPRE were named according to the internal promoter and whether the WPRE or the SIN deletion was present. The purified hematopoietic cells were transduced, grown in liquid culture in the presence of IL-3, IL-6, and SCF for 3 days, and then analyzed by FACS. The vector containing the EF-1 promoter generated the highest mean fluoresence intensity (MFI) among the GFP⁺ cells by FACS (EF-1, 179 ± 8; PGK, 58 ± 3; CMV, 39 ± 2; CAG, 40 ± 0.5; n = 3 experiments) and was comparable to the MFI (162 ± 2) generated by the oncoretrovirus, vector MGIN (Fig. 3). Addition of the WPRE did not provide an improvement in murine hematopoietic cells, in contrast to the human cell lines HeLa and 293T, where two- to threefold improvement was seen (data not shown). Inclusion of the SIN deletion did not have a clear effect on the expression levels in murine hematopoietic cells (data not shown). Therefore, we chose the EF-1 vector without addition of the WPRE element and without the SIN deletion for all further experiments presented below.

View larger version (38K): [in this window] [in a new window]   FIG. 3.   Effects of vector design on levels of GFP expression in Lin c-kit+ Sca1+ hematopoietic cells transduced with lentivirus vectors with different internal promoters. The MFI generated by the expression of the GFP is shown ± the standard error of the mean (n = 3 experiments). Purified cells were transduced as described in Materials and Methods, then grown in liquid culture containing IL-3, IL-6, and SCF for 3 days, and analyzed by FACS.

Gene transfer efficiencies of lentivirus vectors in Lin c-kit⁺ Sca1⁺ murine hematopoietic progenitor cells. Lentivirus gene transfer efficiency in Lin c-kit⁺ Sca1⁺ clonogenic progenitors was analyzed in methylcellulose colony assays. The lentivirus vector transduction efficiency, as scored by the percentage of GFP⁺ colonies in methylcellulose, was high under all 20-h transduction conditions tested. The scoring was initially performed by microscopy and confirmed by FACS analysis of the individual GFP⁺ colonies. If the transduction was performed without cytokines or serum, the transduction efficiency with the lentivirus vector was 27.3 ± 6.7%, whereas there was no significant transduction with the oncoretrovirus control (1.26 ± 0.8% with the concentrated supernatant under serum-free conditions, or 1.7 ± 0.3% with the unconcentrated supernatant with a final serum concentration of 3%) (Fig. 4). The lentivirus transduction efficiency within the clonogenic progenitors was higher if cytokine support was used. When SCF was added, lentivirus transduction generated 42.0 ± 5.5% GFP⁺ colonies, in contrast to the concentrated and unconcentrated oncoretrovirus MGIN controls, which resulted in 3.3 ± 1.8 and 9.7 ± 1.8% GFP⁺ colonies, respectively. When transduction was performed with SCF, IL-6, and IL-3, 53.3 ± 1.8% of the lentivirus-transduced colonies were positive for GFP, in comparison to 9.3 ± 1.2% (serum free) and 39.3 ± 9.4% (with serum) of the oncoretrovirus controls.

View larger version (20K): [in this window] [in a new window]   FIG. 4.   Transduction efficiency with lentivirus and oncoretrovirus vectors as judged by percent GFP+ colonies in methylcellulose assays. The transductions were performed under serum-free conditions (with the exception of unconcentrated MGIN supernatant, resulting in a final serum concentration of 3%) with an MOI of 100. The number of GFP+ colonies was scored by microscopy and confirmed by FACS (n = 3 experiments).

Heterogeneity of GFP expression within GFP⁺ colonies. Although lentivirus transduction resulted in a high percentage of GFP⁺ colonies, microscopy and FACS analysis of individual GFP⁺ colonies revealed that only a portion of the cells within each colony expressed the GFP gene (Fig. 5). The ratio of GFP⁺ cells within each colony was lowest when no cytokines were used during transduction (19.2 ± 5.0%), in comparison with 34.2 ± 6.0% when SCF was used alone and 45 ± 11% when SCF, IL-6, and IL-3 were used during transduction. In contrast, 87.8 ± 5.2% of the cells in GFP⁺ colonies transduced in the presence of IL-3, IL-6, and SCF with the MGIN oncoretrovirus, control vector were GFP⁺ (Fig. 5, bottom). Mosaicism of GFP expression was observed in transduced colonies from all lentivirus-vectors tested, irrespective of the nature of the internal promoter (data not shown).

View larger version (134K): [in this window] [in a new window]   FIG. 5.   Mosaicism of GFP expression in lentivirus transduced hematopoietic colonies. (Top) GFP+ methylcellulose colonies 6 days after transduction of Lin c-kit+ Sca1+ cells by a lentivirus vector with EF-1 as an internal promoter. Two colonies are shown with phase-contrast microscopy (lower panels) and fluorescent microscopy (upper panels). In each colony it can be seen that only a fraction of the cells are expressing the GFP transgene. (Bottom) FACS analysis of GFP expression within individual GFP+ methylcellulose colonies. Each circle represents a single colony.

Analysis of secondary hematopoietic colonies for GFP expression and presence of the vector genome. To study whether the heterogeneity of GFP expression in the methylcellulose colonies was due to transcriptional silencing or true genetic mosaicism with respect to the presence of the proviral vector genome, individual GFP⁺ colonies were plated further for secondary colony assays. Purified hematopoietic progenitors were transduced in the presence of IL-3, IL-6, and SCF, then plated into methylcellulose cultures, and GFP⁺ hematopoietic colonies of various types or morphologies (colony-forming units mix [CFU-mix], colony-forming units granulocyte-macrophage [CFU-GM], etc.) were picked at days 5 to 6 and plated into secondary methylcellulose cultures. Individual secondary colonies were then scored for GFP expression by FACS and for the presence of vector genome in the daughter cells by PCR. Within the 30 secondary colonies that derived from 7 different primary GFP⁺ colonies, only 42% were GFP positive by both FACS and PCR (Table 1). None of the colonies were positive by FACS without being PCR positive, demonstrating the high sensitivity of the PCR assay. Approximately half of the colonies (46%) were negative both by FACS and by PCR. Some of the colonies (13%) were positive by PCR without demonstrating any expression of GFP by FACS, representing either integrated copies where the expression from the EF-1 promoter was silenced or cases where the GFP gene was amplified by PCR from a nonintegrated vector. The presence of GFP PCR daughter colonies in the progeny of primary GFP⁺ colonies indicates that the lentivirus gene transfer is not fully completed between the time of transduction and the time when the transduced progenitor divides. Therefore, the vector genome seems to integrate after proliferation in the methylcellulose culture starts, and as a consequence, vector integration is seen in only a portion of each progenitor's progeny cells. In contrast, all secondary colonies derived from the oncoretrovirus-transduced colonies expressed GFP and contained the proviral DNA, as detected by PCR. The difference between the number of secondary colonies containing the lentiviral and oncoretroviral DNA, respectively, is highly significant by the chi-square test (P < 0.01).

View this table: [in this window] [in a new window]   TABLE 1.   Lentivirus transduced GFP+ primary hematopoietic colonies generate GFP secondary colonies lacking the provirusa

Effect of time and proliferation kinetics after transduction on heterogeneity of GFP expression and final gene transfer efficiency. To study the time course needed for completion of lentivirus gene transfer in mouse hematopoietic progenitor cells, the transduced cells were cultured for an extended period (an additional 24 to 72 h) before plating into methylcellulose clonal assays. By delaying the start of a clonal assay after transduction in SCF, the degree of mosaicism was reduced. The percentage of GFP⁺ cells within the GFP⁺ colonies increased from 34 ± 8% at day 0 to 55 ± 6% when the cells were plated at day 1 posttransduction and to 61 ± 9 and 68 ± 11% at days 2 and 3 posttransduction, respectively (Fig. 6A). The difference between day 0 and day 3 was significant (P < 0.02), as was the difference between day 0 and day 2 (P < 0.05), by Student's t test. The difference between day 0 and day 1 was not statistically significant (P = 0.11).

View larger version (22K): [in this window] [in a new window]   FIG. 6.   Effect of extended culture time on mosaicism within GFP+ colonies. (A) Transduction was performed with SCF for 20 h, after which the cells were cultured in SCF for an additional 1 to 3 days and plated in methylcellulose. The percentage of GFP-expressing cells in individual colonies was analyzed by FACS. Results for 10 GFP+ colonies from each day are shown (each colony is represented by an open circle). The mean value is indicated by a horizontal line among the circles. (B) Effect of 2 days of extended culture with SCF alone (open bars) or with IL-3, IL-6, and SCF (shaded bars) on the total percentage of GFP+ cells. After transduction with or without 2 days of extended culture, the cells were plated in methylcellulose. After methylcellulose culture the colonies in each plate were pooled, and the progeny cells were analyzed for GFP expression by FACS. The difference between day 0 and day 2 is statistically significant with SCF alone (P < 0.03; n = 3), but there is no significant difference between day 0 and day 2 when all three cytokines are used.

Effect of a second hit on gene transfer efficiency. To evaluate whether transduction efficiency could be improved further by exposing the cells for two hits of viral transduction, the transduction time was increased by an additional 20 h by adding the same amount of fresh vector to the cells. Here, the second hit could be performed only with cytokine support due to reduction of viability under cytokine-depleted conditions. The exposure of the cells for a second hit was shown to improve the ratio of GFP⁺ colonies marginally, from 40 ± 8% to 49 ± 2% with transduction in the presence of SCF alone and from 51 ± 14% to 61 ± 9% with SCF, IL-6, and IL-3 (Fig. 7A). A clear difference, however, was seen when the total percentage of GFP⁺ cells in the methylcellulose culture was evaluated. As shown in Fig. 7B, the total numbers of GFP⁺ cells rose from 15 ± 1% to 24 ± 2% with SCF alone (statistically significant; P < 0.05), and from 18 ± 2% to 43 ± 8% with SCF, IL-6, and IL-3 (statistically significant; P < 0.05). When the transduction efficiency was high, e.g., when more than 60% of the colonies and 40% of the total cells were GFP positive, the second hit was also shown to increase the MFI of GFP-positive cells (data not shown). These results together suggest that the second exposure to the lentivirus vector may facilitate entry of more viral particles into the target cell population, as well as give more time to complete the integration process before plating for clonal assays, thus increasing the percentage of GFP⁺ cells in the progeny.

View larger version (25K): [in this window] [in a new window]   FIG. 7.   Effect of a second vector hit on lentivirus transduction efficiency. Hematopoietic stem cells were transduced for 20 h with SCF alone or SCF, IL-3, and IL-6 and then either plated directly on methylcellulose or transduced for an additional 20 h with the addition of fresh viral supernatant. (A) The percentage of GFP+ colonies was scored by microscopy. The second hit does not increase the number of positive colonies significantly. (B) Total GFP+ cells within all colonies as determined by FACS analysis. The second hit increases the percentage of positive cells with SCF alone and with IL-3, IL-6, and SCF (P < 0.05). For both panels, open bars indicate one transduction; shaded bars indicate two transductions (n = 3 experiments).

Effect of exogenous dNTP supplementation on gene transfer efficiency. In an attempt to further improve the gene transfer process in murine hematopoietic progenitors and stem cells, deoxynucleotides were added during transduction. Addition of 50 µM dNTPs was shown to increase the total ratio of GFP⁺ cells under all conditions tested, from 6.5 ± 1.0% to 14.4 ± 0.6% (significant difference; P < 0.01) if the transduction was performed without cytokine support, from 11.6 ± 1.2% to 17.4 ± 1.2% (significant difference; P < 0.02) with SCF alone, and from 15.7 ± 0.1% to 28.1 ± 1.0% (significant difference; P < 0.01) with SCF, IL-6, and IL-3 (Fig. 8). The ratio of GFP⁺ colonies in methylcellulose or the MFI was not changed, indicating that the improvement in the ratio of the GFP⁺ cells by addition of dNTPs was achieved mainly by a decrease in mosaicism within individual colonies. This was further shown by FACS analysis of individual colonies transduced without cytokine stimulation. The addition of exogenous dNTPs increased the mean percentage of GFP⁺ cells within the GFP⁺ colonies from 19.2 ± 5.3% to 40.2 ± 6.2% (n = 10 colonies in each group).

View larger version (31K): [in this window] [in a new window]   FIG. 8.   The effect of exogenous nucleotides on lentivirus transduction efficiency was studied by supplementation with 50 µM dNTPs during transduction. (A) The transduced cells were cultured in methylcellulose, and the number of GFP+ was colonies determined by microscopy. No significant difference in the number of positive colonies was seen with the addition of dNTPs. (B) Percentage of GFP+ cells (as determined by FACS analysis) with (shaded bars) or without (open bars) added exogenous nucleotides. The percentage of GFP+ cells increased significantly with the addition of dNTPs under all growth conditions shown (see the text).

	DISCUSSION

Top Abstract Introduction Materials and Methods Results Discussion References

The aim of this study was to investigate the capability of lentivirus vectors to transduce and express genes in primitive murine hematopoietic progenitor cells and their progeny, in an effort to create a mouse model for lentivirus gene transfer for future studies involving testing of new expression cassettes and therapeutic genes in a true in vivo model. Furthermore, the aim was to gain insight into the prerequisites for optimal gene transfer of hematopoietic cells by lentivirus vectors, by studying the gene transfer efficiency into quiescent as well as cytokine-stimulated primitive murine hematopoietic progenitor cells. Lin c-kit⁺ Sca1⁺ cells were obtained from the bone marrow by depleting the cells expressing lineage-specific markers, and further sorting for c-kit⁺ Sca1⁺ cells, resulting in a 1,000-fold enrichment for primitive hematopoietic progenitor and stem cells. In an effort to achieve high transgene expression levels in murine hematopoietic cells, different lentivirus vector were tested in these target cells and their progeny. Our results show that high expression levels of the GFP marker gene can be obtained by using the EF-1 promoter in the lentivirus vector. The expression level from the EF-1 lentivirus vector was similar to the level from the oncoretrovirus LTR in the MGIN vector, which expresses very well in hematopoietic cells (8).

Using the EF-1 lentivirus vector, we studied how mouse hematopoietic progenitor cells can be transduced most efficiently. Our results demonstrate that the VSV-G-pseudotyped lentivirus vectors can transduce a high percentage of murine Lin c-kit⁺ Sca1⁺ hematopoietic stem cells with or without cytokine stimulation, as judged by the ratio of GFP-positive colonies in clonogenic progenitor assays. However, the transduction efficiency was consistently higher when the transduction was performed with cytokine support. Supplementation with SCF during transduction increased the transduction efficiency, although SCF alone will not induce rapid cell division. The transduction efficiency was increased further by using SCF, IL-6, and IL-3, a combination that effectively stimulates proliferation of hematopoietic progenitor and stem cells. The oncoretrovirus control vector did not show significant transduction unless the cells were stimulated with SCF, IL-6, and IL-3. It is known that optimal oncoretrovirus transduction requires longer cytokine stimulation than the 20-h transduction protocol used here allows (8). These results demonstrate the superiority of lentivirus gene transfer to oncoretrovirus transduction when the cells to be transduced have undergone little or no activation. However, the efficiency of lentivirus transduction of murine hematopoietic progenitors was increased for cytokine-stimulated cells. This is consistent with the results of Sutton et al. (39), which showed that the efficiency of transduction of human CD34⁺ hematopoietic cells is higher when they are in the G₁ or G₂/S/M phase of the cell cycle than when they are in G₀. Cell cycle activity is probably not required for lentivirus vector transduction of hematopoietic progenitors, in contrast to murine hepatocytes, which need to be actively dividing in order to be efficiently transduced in vivo (34).

Interestingly, when the daughter cells within individual GFP⁺ colonies in methylcellulose were analyzed for GFP expression by flow cytometry, only a portion of the cells were found to express GFP. In contrast, GFP expression was more homogeneous in colonies transduced with the oncoretrovirus control vector. The heterogeneity of GFP expression in the lentivirus transduced colonies was most evident if the transduction was performed without cytokine stimulation. The lack of GFP expression in a portion of cells within the progeny of a single transduced progenitor cell raised the question of whether the GFP mosaicism observed is true genetic mosaicism with respect to the presence of the integrated proviral vector genome or is due to transcriptional silencing of the internal promoter in the vector. To address this question, the progeny cells from individual GFP-positive colonies were plated into secondary methylcellulose culture, and the secondary colonies were analyzed for the presence of the viral genome and GFP expression. Interestingly, both GFP⁺ PCR⁺ as well as GFP PCR secondary colonies originating from the primary GFP⁺ colonies were found. Some of the colonies were positive by PCR without showing any detectable GFP expression by FACS. These colonies may represent colonies that contain the proviral genome but are transcriptionally inactive. The presence of both GFP⁺ PCR⁺ and GFP PCR secondary colonies in the progeny of a single cell demonstrates true genetic mosaicism with respect to the vector genome in the progeny cells, suggesting a latency of viral integration using these vectors, target cells, and transduction conditions. It is also possible that the vector has integrated initially but has subsequently been lost from the target cell. This possibility is not likely.

To study whether vector mosaicism in the progeny cells was the result of delayed integration, we tested whether the degree of GFP heterogeneity within the colonies could be reduced by extending the time available for integration before the transduced cells were plated for clonal assays. The results show that the degree of GFP mosaicism could be reduced if the colony assay was started at later time points, suggesting that lentivirus integration cannot always be completed during the time from the beginning of transduction until progenitor proliferation starts. If the extended culture was performed under low proliferative conditions, with SCF alone, the number of positive colonies was maintained, and the final ratio of GFP⁺ cells in their progeny could be increased. In contrast, when the cells were cultured after transduction under high proliferative conditions, with SCF, IL-6, and IL-3, the total percentage of GFP⁺ cells was not increased by extended liquid culture. These results, taken together, show that although murine Lin c-kit⁺ Sca1⁺ hematopoietic progenitor cells can be more readily transduced with cytokine stimulation than without, rapid cell division prior to integration may result in loss of the unintegrated vector genome from some of the progeny cells, lowering the total gene transfer efficiency. In support of the concept of delayed integration of lentivirus vectors is evidence that wild-type HIV-1 proviral DNA can persist as long as 3 weeks extrachromosomally in quiescent T cells prior to integrating upon T-cell activation (37).

The results with the lentivirus transduction of mouse hematopoietic stem cells and progenitor cells point out that although viral entry with the VSV-G envelope in these target cells appears to be efficient, as shown by the high ratio of GFP⁺ colonies in the methylcellulose assay, there may be other bottlenecks that compromise the final gene transfer efficiency in the progeny. In addition to entry into the target cells, optimal gene transfer requires efficient reverse transcription of the viral RNA, transport into the nucleus, and integration in the genome of the target cell. Our aim was to see whether we could affect any of these processes and increase overall transduction efficiency as well as decrease the GFP mosaicism within the progeny cells. In an effort to maximize vector entry into the target cells, the cells were exposed for a second hit of vector together with prolongation of the transduction time by an additional 20 h. Indeed, a second exposure to the vector increased the final gene transfer efficiency twofold, as determined by the ratio of GFP⁺ cells in the progeny, with a modest increase in the ratio of GFP⁺ colonies. When the overall transduction efficiency was high, e.g., over 40% GFP⁺ cells, an increase in the MFI was also observed. These results show that the double transduction may be useful if high gene transfer efficiency is required. The beneficial effect may in part depend on entry of more viral copies into the target population, and in part on the extended time available to complete gene transfer before rapid proliferation of the target cells ensues. It is of interest in this context that a recent report demonstrates that the 99-nucleotide central DNA flap that creates a DNA triplex in HIV-1 will increase the nuclear import of HIV-1 and HIV-1-based vectors (42). It is possible that the presence of this sequence, which is lacking in our vectors, would increase gene transfer efficiency and reduce the mosaicism in the progeny of the target cells.

The transduction efficiency of hematopoietic progenitors was lowest, and the mosaicism within the colonies was highest, when the cells were transduced without any cytokine support. Studies with wild-type HIV and other retroviruses have shown that reverse transcription of the virus cannot be efficiently completed in quiescent lymphocytes, or the mutation rate in the reverse transcripts may be higher (14, 17, 20, 21). One factor hindering reverse transcription may be nucleotide imbalances (24) in quiescent cells. Attempts have been made to improve retrovirus transduction efficiency by supplementing with nucleotides before transduction (43); however, no significant improvement due to dNTPs was seen in transducing rat neurons with lentivirus vectors (2). Interestingly, in hematopoietic progenitor cells, supplementation of the transduction mixture with 50 µm dNTPs increased the ratio of GFP⁺ cells in the progeny roughly two-fold. The effect was seen most clearly in the unstimulated cells. The number of transduced colonies was not changed, although the overall ratio of the GFP⁺ cells within the colonies doubled, indicating that the mosaicism of GFP expression in the colonies could be reduced by providing exogenous nucleotides during transduction. This raises the possibility that reverse transcription might be a rate-limiting step for the rapid establishment of the lentiviral provirus in mouse hematopoietic progenitor cells.

In conclusion, we have found that mouse Lin c-kit⁺ Sca1⁺ hematopoietic stem and progenitor cells are sensitive targets for lentivirus gene transfer, and high expression levels can be achieved by using EF-1 as an internal promoter. However, the final gene transfer efficiency with the vector type used depends on the growth conditions during and after transduction. Cytokine stimulation or, alternatively, supplementation with nucleotides during transduction was associated with higher gene transfer efficiency, whereas rapid proliferation after transduction resulted in a lower ratio of GFP-expressing progeny cells. These findings may help in understanding the mechanisms affecting lentivirus gene transfer efficiency in hematopoietic progenitor and stem cells, and in developing optimal transduction protocols for these target cells.